Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Robert Keith

Concepts (301)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
54
2024
2637
5.040
 Why?
Precancerous Conditions
11
2024
166
2.610
 Why?
Carcinoma, Squamous Cell
11
2023
641
2.070
 Why?
Epoprostenol
12
2021
131
2.040
 Why?
Chemoprevention
8
2023
90
1.760
 Why?
Cancer Survivors
4
2023
327
1.620
 Why?
Iloprost
10
2023
44
1.530
 Why?
Carcinoma, Non-Small-Cell Lung
10
2024
1180
1.480
 Why?
Carmustine
3
2020
52
1.450
 Why?
Smoke
4
2020
148
1.250
 Why?
Bronchi
10
2018
267
1.210
 Why?
Intramolecular Oxidoreductases
8
2018
66
1.150
 Why?
Cytochrome P-450 Enzyme System
8
2018
162
1.080
 Why?
Smoking
16
2019
1472
0.940
 Why?
Telerehabilitation
1
2023
43
0.750
 Why?
Carcinoma in Situ
5
2019
44
0.750
 Why?
Leisure Activities
1
2021
30
0.660
 Why?
Lung
16
2023
4109
0.640
 Why?
Respiratory System
1
2020
149
0.600
 Why?
Antineoplastic Agents
7
2013
2194
0.590
 Why?
Carcinogens
6
2022
122
0.560
 Why?
Frizzled Receptors
2
2016
25
0.560
 Why?
Disease Models, Animal
6
2022
4557
0.560
 Why?
Tobacco Smoke Pollution
1
2020
233
0.550
 Why?
Pulmonary Disease, Chronic Obstructive
7
2020
920
0.540
 Why?
Biomarkers, Tumor
9
2015
1313
0.540
 Why?
Neoplasms, Experimental
2
2018
173
0.530
 Why?
Bronchial Neoplasms
3
2011
15
0.490
 Why?
Urethane
4
2022
43
0.490
 Why?
Mice
24
2023
18339
0.460
 Why?
Hospitalists
1
2020
266
0.450
 Why?
PPAR gamma
3
2022
176
0.450
 Why?
Antihypertensive Agents
2
2017
510
0.450
 Why?
Sputum
8
2019
308
0.440
 Why?
Bronchopulmonary Dysplasia
1
2019
410
0.410
 Why?
Telemedicine
1
2023
945
0.400
 Why?
Animals
29
2023
38058
0.390
 Why?
Mice, Transgenic
9
2018
2182
0.390
 Why?
Trachea
1
2015
261
0.380
 Why?
Quality of Life
4
2023
3185
0.380
 Why?
MicroRNAs
2
2016
701
0.370
 Why?
Bronchoscopy
7
2019
227
0.360
 Why?
Adenocarcinoma
3
2017
928
0.360
 Why?
Practice Guidelines as Topic
1
2020
1560
0.350
 Why?
Hyperplasia
2
2011
174
0.350
 Why?
Biopsy
10
2023
1075
0.340
 Why?
Cell Transformation, Neoplastic
4
2023
339
0.340
 Why?
Vasodilator Agents
2
2011
331
0.310
 Why?
Humans
54
2024
144759
0.310
 Why?
Receptors, Epoprostenol
1
2008
5
0.290
 Why?
Exercise
1
2021
2201
0.280
 Why?
Epithelial-Mesenchymal Transition
2
2022
219
0.280
 Why?
Quinazolines
1
2010
266
0.280
 Why?
Gene Expression Regulation
2
2016
2608
0.280
 Why?
Lung Diseases, Obstructive
1
2007
43
0.250
 Why?
Receptors, Prostaglandin E
1
2006
7
0.250
 Why?
Dinoprostone
5
2010
178
0.230
 Why?
Neovascularization, Pathologic
4
2015
286
0.230
 Why?
Desmoglein 3
2
2022
14
0.220
 Why?
Biomedical Research
1
2011
710
0.220
 Why?
Female
24
2022
78271
0.210
 Why?
Disease Progression
7
2024
2847
0.200
 Why?
Adrenal Cortex Hormones
1
2007
478
0.200
 Why?
Chromosome Aberrations
4
2013
162
0.200
 Why?
Protein Kinase Inhibitors
1
2010
969
0.200
 Why?
Drug Evaluation, Preclinical
2
2017
194
0.190
 Why?
Anticarcinogenic Agents
2
2018
61
0.190
 Why?
Keratin-5
1
2022
48
0.180
 Why?
Formaldehyde
1
2022
66
0.180
 Why?
Clinical Trials as Topic
3
2013
1053
0.180
 Why?
Mice, Inbred A
2
2020
48
0.180
 Why?
Risk Factors
7
2021
10779
0.180
 Why?
Butylated Hydroxytoluene
4
2006
36
0.180
 Why?
Cross-Sectional Studies
4
2021
5868
0.170
 Why?
Smokers
2
2019
137
0.170
 Why?
Confidence Intervals
2
2021
333
0.170
 Why?
Placebos
2
2019
192
0.170
 Why?
Tubulin
1
2022
147
0.170
 Why?
Behavioral Risk Factor Surveillance System
1
2021
59
0.170
 Why?
Double-Blind Method
2
2019
2029
0.160
 Why?
Respiratory Mucosa
3
2015
322
0.160
 Why?
United States
4
2024
15966
0.160
 Why?
Neoplasm Invasiveness
6
2015
508
0.160
 Why?
Middle Aged
20
2021
35875
0.160
 Why?
Societies, Medical
1
2024
887
0.160
 Why?
Epithelial Cells
4
2018
1125
0.150
 Why?
Aged
18
2021
25913
0.150
 Why?
Carcinogenesis
1
2021
229
0.150
 Why?
Male
27
2021
72315
0.150
 Why?
Air Pollution
1
2023
327
0.150
 Why?
Ki-67 Antigen
4
2015
117
0.150
 Why?
ErbB Receptors
3
2023
627
0.150
 Why?
Lung Diseases
3
2015
787
0.140
 Why?
United Kingdom
1
2020
338
0.140
 Why?
Remission Induction
1
2019
307
0.140
 Why?
Rats
5
2010
5597
0.140
 Why?
Pulmonary Emphysema
3
2007
275
0.140
 Why?
Air Pollutants
1
2023
438
0.140
 Why?
Receptors, Prostaglandin
1
2017
21
0.130
 Why?
Mice, Inbred BALB C
3
2011
1253
0.130
 Why?
Receptors, G-Protein-Coupled
2
2010
233
0.130
 Why?
Biological Availability
1
2017
142
0.130
 Why?
Receptors, CXCR4
1
2017
91
0.130
 Why?
RNA, Messenger
3
2022
2832
0.120
 Why?
Self Report
1
2021
872
0.120
 Why?
Socioeconomic Factors
1
2021
1326
0.120
 Why?
Chromosomal Instability
2
2013
21
0.120
 Why?
In Situ Hybridization, Fluorescence
4
2010
322
0.110
 Why?
Logistic Models
1
2021
2117
0.110
 Why?
Mitotic Index
1
2015
25
0.110
 Why?
Health Status
1
2021
836
0.110
 Why?
Smoking Cessation
1
2019
439
0.110
 Why?
Signal Transduction
5
2013
5226
0.110
 Why?
Phospholipases A
2
2006
98
0.110
 Why?
Sensitivity and Specificity
7
2010
1985
0.110
 Why?
Macrophages, Alveolar
3
2023
368
0.110
 Why?
Methylcholanthrene
2
2006
21
0.110
 Why?
Cell Proliferation
3
2018
2496
0.110
 Why?
Neoplasm Grading
1
2015
307
0.100
 Why?
Mental Health
1
2021
790
0.100
 Why?
Macrophages
2
2020
1511
0.100
 Why?
Microarray Analysis
1
2013
117
0.100
 Why?
Tertiary Prevention
1
2013
3
0.100
 Why?
Stem Cells
1
2018
626
0.100
 Why?
Immunoenzyme Techniques
2
2011
200
0.100
 Why?
Inflammation
3
2018
2878
0.090
 Why?
Pulmonary Alveoli
2
2006
383
0.090
 Why?
Treatment Outcome
4
2018
11679
0.090
 Why?
Secondary Prevention
1
2013
254
0.090
 Why?
Administration, Topical
1
2011
150
0.090
 Why?
Cell Line, Tumor
2
2017
3540
0.080
 Why?
Primary Prevention
1
2013
220
0.080
 Why?
Immunohistochemistry
5
2015
1716
0.080
 Why?
Time Factors
2
2021
7173
0.080
 Why?
Cells, Cultured
2
2016
4154
0.080
 Why?
Tumor Cells, Cultured
2
2010
919
0.080
 Why?
Biomarkers
4
2023
4271
0.080
 Why?
Isotretinoin
1
2009
26
0.070
 Why?
Tocopherols
1
2009
30
0.070
 Why?
Surveys and Questionnaires
1
2021
6048
0.070
 Why?
rho GTP-Binding Proteins
1
2009
56
0.070
 Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
 Why?
Gene Expression Regulation, Neoplastic
3
2018
1455
0.070
 Why?
Cadherins
1
2010
201
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2005
758
0.070
 Why?
Glycoproteins
1
2010
355
0.070
 Why?
6-Ketoprostaglandin F1 alpha
2
2004
18
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Adenoma
1
2010
218
0.070
 Why?
Loss of Heterozygosity
2
2013
52
0.060
 Why?
Phagocytosis
1
2009
299
0.060
 Why?
Endothelium, Vascular
2
2007
965
0.060
 Why?
Acrolein
1
2007
22
0.060
 Why?
Cytosol
2
2006
227
0.060
 Why?
Genome-Wide Association Study
1
2013
1406
0.060
 Why?
Survival Rate
1
2011
2089
0.060
 Why?
Receptors, Prostaglandin E, EP2 Subtype
1
2006
6
0.060
 Why?
Cell Growth Processes
1
2006
50
0.060
 Why?
Amiodarone
1
2006
31
0.060
 Why?
Polymorphism, Single Nucleotide
1
2013
2145
0.060
 Why?
Follow-Up Studies
2
2015
5408
0.060
 Why?
Administration, Inhalation
1
2007
574
0.060
 Why?
Periodontal Diseases
1
2006
62
0.060
 Why?
Mice, Knockout
3
2009
3121
0.060
 Why?
Anti-Arrhythmia Agents
1
2006
142
0.060
 Why?
Leukocytes
1
2006
295
0.050
 Why?
Mice, Inbred C57BL
4
2008
5992
0.050
 Why?
Genotype
1
2008
1833
0.050
 Why?
Bronchiolitis
1
2004
87
0.050
 Why?
Case-Control Studies
5
2012
3604
0.050
 Why?
Bronchoalveolar Lavage Fluid
2
2006
636
0.050
 Why?
Pulmonary Embolism
1
2006
244
0.050
 Why?
Aged, 80 and over
7
2015
8265
0.050
 Why?
Apoptosis
2
2009
2430
0.050
 Why?
Carcinoma, Bronchogenic
1
2002
20
0.050
 Why?
Tomography, Spiral Computed
1
2002
30
0.050
 Why?
Patient Compliance
1
2007
588
0.050
 Why?
Muscles
1
2023
333
0.050
 Why?
Pulmonary Artery
2
2005
1134
0.050
 Why?
Antioxidants
2
2006
549
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
557
0.050
 Why?
Alveolar Epithelial Cells
1
2023
120
0.040
 Why?
Dyspnea
1
2023
251
0.040
 Why?
Particle Size
1
2023
411
0.040
 Why?
Gene Expression Profiling
2
2005
1782
0.040
 Why?
Neoplasm Proteins
1
2004
442
0.040
 Why?
Interleukin-1beta
1
2023
395
0.040
 Why?
Hemorrhage
1
2006
809
0.040
 Why?
Research Design
1
2007
1135
0.040
 Why?
Cell Line
2
2018
2882
0.040
 Why?
Weight Gain
1
2004
556
0.040
 Why?
Chromosomes, Human, Pair 3
1
2000
43
0.040
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
49
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2010
983
0.040
 Why?
Particulate Matter
1
2023
347
0.040
 Why?
Prevalence
2
2023
2834
0.040
 Why?
Tuberculosis
1
2003
291
0.040
 Why?
Survivors
1
2023
520
0.040
 Why?
Sepsis
1
2006
640
0.040
 Why?
Cell Cycle Proteins
2
2018
628
0.040
 Why?
Cohort Studies
2
2023
5960
0.040
 Why?
Enzyme Inhibitors
1
2022
824
0.040
 Why?
gamma Catenin
1
2018
13
0.040
 Why?
Walking
1
2023
545
0.040
 Why?
Tobacco Smoking
1
2018
26
0.030
 Why?
Metaplasia
1
2018
57
0.030
 Why?
Cell Division
1
2000
766
0.030
 Why?
Bronchial Diseases
1
2018
38
0.030
 Why?
Environmental Exposure
1
2023
588
0.030
 Why?
Time
1
2018
86
0.030
 Why?
Cell Cycle Checkpoints
1
2018
99
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
1953
0.030
 Why?
Pilot Projects
1
2023
1886
0.030
 Why?
Prognosis
1
2006
4282
0.030
 Why?
ROC Curve
2
2010
614
0.030
 Why?
Epithelium
1
2018
314
0.030
 Why?
Genetic Predisposition to Disease
1
2005
2363
0.030
 Why?
Tumor Suppressor Protein p53
1
2000
529
0.030
 Why?
Adult
7
2018
40449
0.030
 Why?
Prospective Studies
2
2023
7990
0.030
 Why?
Hypoxia
1
2003
1199
0.030
 Why?
Phospholipases A2
2
2006
79
0.030
 Why?
Proto-Oncogene Proteins
1
2018
623
0.030
 Why?
Neoplasm Staging
2
2010
1462
0.030
 Why?
Mass Screening
1
2002
1347
0.030
 Why?
Endoscopy
1
2015
316
0.020
 Why?
Risk
2
2007
911
0.020
 Why?
Veterans
1
2002
1603
0.020
 Why?
Administration, Oral
1
2012
847
0.020
 Why?
Incidence
2
2010
2879
0.020
 Why?
Severity of Illness Index
1
2018
2925
0.020
 Why?
Luciferases
1
2010
152
0.020
 Why?
Area Under Curve
1
2010
330
0.020
 Why?
International Agencies
1
2009
30
0.020
 Why?
Mice, Inbred ICR
1
2009
113
0.020
 Why?
Mutation
1
2000
4089
0.020
 Why?
rhoA GTP-Binding Protein
1
2009
76
0.020
 Why?
rho-Associated Kinases
1
2009
83
0.020
 Why?
Fluorescence
1
2009
161
0.020
 Why?
Cytotoxins
1
2007
16
0.020
 Why?
Blotting, Western
1
2010
1187
0.020
 Why?
Platinum
1
2007
50
0.020
 Why?
Carboplatin
1
2007
160
0.020
 Why?
Airway Obstruction
1
2009
162
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
459
0.020
 Why?
Bevacizumab
1
2007
167
0.020
 Why?
Minichromosome Maintenance Complex Component 2
1
2006
4
0.020
 Why?
Chemokine CCL8
1
2006
3
0.020
 Why?
Monocyte Chemoattractant Proteins
1
2006
7
0.020
 Why?
Paclitaxel
1
2007
255
0.010
 Why?
Databases, Nucleic Acid
1
2005
39
0.010
 Why?
Angiogenesis Inhibitors
1
2007
237
0.010
 Why?
Chemokine CCL2
1
2006
115
0.010
 Why?
Enzymes
1
2005
65
0.010
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.010
 Why?
Species Specificity
1
2005
574
0.010
 Why?
Microsomes
1
2004
33
0.010
 Why?
Cyclooxygenase 1
1
2004
26
0.010
 Why?
Cluster Analysis
1
2005
521
0.010
 Why?
Tachycardia, Ventricular
1
2006
181
0.010
 Why?
Cell Culture Techniques
1
2007
375
0.010
 Why?
Prostaglandin-Endoperoxide Synthases
1
2004
74
0.010
 Why?
Tumor Necrosis Factor-alpha
1
2009
1217
0.010
 Why?
Tomography, X-Ray Computed
2
2006
2730
0.010
 Why?
Prostaglandins
1
2004
94
0.010
 Why?
Arachidonic Acid
1
2004
101
0.010
 Why?
DNA Replication
1
2005
251
0.010
 Why?
Immunoblotting
1
2004
300
0.010
 Why?
Evidence-Based Medicine
1
2007
732
0.010
 Why?
Cyclooxygenase 2
1
2004
165
0.010
 Why?
Isoenzymes
1
2004
299
0.010
 Why?
Vital Capacity
1
2004
290
0.010
 Why?
Predictive Value of Tests
1
2009
2115
0.010
 Why?
Osteopontin
1
2003
34
0.010
 Why?
Neutrophils
1
2009
1134
0.010
 Why?
Forced Expiratory Volume
1
2004
449
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2005
851
0.010
 Why?
Solitary Pulmonary Nodule
1
2002
23
0.010
 Why?
Sialoglycoproteins
1
2003
158
0.010
 Why?
Neoplasm Recurrence, Local
1
2009
1137
0.010
 Why?
Oxidative Stress
1
2009
1339
0.010
 Why?
Drainage
1
2003
185
0.010
 Why?
Up-Regulation
1
2005
851
0.010
 Why?
Sex Factors
1
2007
2112
0.010
 Why?
Hospitals, Veterans
1
2002
259
0.010
 Why?
Antibodies, Monoclonal, Humanized
1
2007
985
0.010
 Why?
Radiation Dosage
1
2002
192
0.010
 Why?
Alleles
1
2004
879
0.010
 Why?
Nuclear Proteins
1
2006
748
0.010
 Why?
Endothelial Cells
1
2007
869
0.010
 Why?
Lipid Metabolism
1
2004
527
0.010
 Why?
Antibodies, Monoclonal
1
2007
1519
0.010
 Why?
Atrial Fibrillation
1
2006
550
0.010
 Why?
RNA
1
2005
940
0.010
 Why?
Feasibility Studies
1
2002
1095
0.010
 Why?
Membrane Proteins
1
2004
1166
0.010
 Why?
Rats, Sprague-Dawley
1
2003
2527
0.010
 Why?
Risk Assessment
1
2004
3671
0.010
 Why?
Colorado
1
2002
4564
0.010
 Why?
Hypertension, Pulmonary
1
2003
1980
0.010
 Why?
Retrospective Studies
1
2005
17066
0.000
 Why?
Keith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (301) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)